||If the form is filed by more than one reporting person, see Instruction 5(b)(v).
||Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
||These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 3,000 RSUs which vest in three equal annual installments of 1,000 each commencing 10/28/2012; 1,493 RSUs which vest in three installments of 492, 493 and 508 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
||These shares include 11 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
||These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
||These stock options are exercisable in two equal annual installments of 920 each commencing on 4/26/2013.
||These stock options are exercisable in two annual installments of 1,724 each on 4/25/2013 and 4/25/2014 and one installment of 1,777 on 4/25/2015.